ReviewFrontiers in immunology2026

Tumor-immune spatiotemporal co-evolution as a paradigm for overcoming therapy resistance in advanced prostate cancer.

Junchao Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.